Skip to main content

Table 1 Reported cases of colon cancer accompanied with tumor thrombus in the superior mesenteric veins

From: Treatment of tumor thrombus in the superior mesenteric vein due to advanced colon cancer with complete surgical resection and chemotherapy: a case report

No. First author Year Age/sex Location of primary lesion Histological type ly/v Complete resection Adjuvant chemotherapy Recurrence Prognosis
1 Kawashima [14] 2007 78/F A Poorly differentiated adenocarcinoma ly3/v3 Done 5-FU/LV Liver(4 M) Dead(5 M)
2 Kanzaki [15] 2009 68/M T Moderately differentiated adenocarcinoma ly2/v3 Done FOLFOX4, UFT/LV (–) Alive(24 M)
3 Yamagami [16] 2009 66/F A Moderately differentiated adenocarcinoma ly2/v3 Done FOLFIRI (–) Alive(22 M)
4 Kamata [17] 2015 70/F A Well-differentiated adenocarcinoma ly1/v1 Done FOLFOX4 (–) Alive(9 M)
5 Tajima [18] 2016 60/F A Moderately differentiated adenocarcinoma ly3/v3 no (–) Liver, dissemination Dead(21 M)
6 Akabane [19] 2018 48/F A Moderately differentiated adenocarcinoma ly0/v2 Done CapeOx (–) Alive(17 M)
7 Kim SE [20] 2019 46/F A Poorly differentiated adenocarcinoma N.D Done FOLFIRI + Bev (–) Alive(12 M)
8 Greally M [21] 2019 54/F T Mucinous adenocarcinoma N.D Done FOLFIRI (–) Alive(18 M)
9 Fujii [22] 2020 82/M A Moderately differentiated adenocarcinoma N.D Done (–) Liver (6 M) Dead(8 M)
10 Our case   72/M T Moderately differentiated adenocarcinoma ly1/v1 Done (–) (–) Alive(36 M)
  1. M male, F female, A ascending colon, T transverse colon, 5-FU fluorouracil, LV leucovorin, UFT tegafur–uracil, Bev bevacizumab, FOLFOX oxaliplatin/5-FU/leucovorin, FOLFIRI irinotecan/5-FU/leucovorin, CapeOx capecitabine/oxaliplatin